• Kaisa Health held a special general meeting on Sept. 1, 2026.
• Shareholders passed a special resolution to change the English name to Qinghai Biotech Pharmaceutical Group.
• The same resolution also adopted the Chinese secondary name 青海生物製藥集團有限公司, replacing 佳兆業健康集團控股有限公司.
• The vote authorized the name changes; the announcement did not confirm the changes have taken effect.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kaisa Health Group Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260901-12314257), on September 01, 2026, and is solely responsible for the information contained therein.